T-β-MCA, a known FXR antagonist, was reported to promote CRC progression in HFD-induced APCmin/+ mice through damaging DNA and increasing proliferation in leucine-rich repeat-containing G protein-coupled receptor 5 positive (LGR5+) cancer stem cells [163]. The gene discussed is LGR5; the disease is cancer.